Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa and is recognized as a leading producer of insulin worldwide. Founded in 1980 under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi, Julphar has remained committed to delivering high-quality, innovative, and affordable healthcare solutions to families across the globe. With a strong focus on three core business units - Julphar Diabetes Solutions, General Medicines, and our consumer division - we offer a wide range of medicines targeting major therapeutic segments such as the Gastrointestinal Tract, Respiratory, Pain Management, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology.

With over 2,500 employees and distribution to more than 50 countries on five continents, our 13 internationally accredited facilities in Africa and the Middle East produce over a million boxes of medicine every day. In 2012, we became one of the world’s largest producers of insulin, thanks to our state-of-the-art biotechnology facility in the UAE. Join us on our mission to provide accessible healthcare solutions and make a positive impact on people's lives